Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
HPV-16 DNA from genital specimens is comparable in three real-time PCR assays
November 24th, 2005
Human papillomavirus-16 DNA from genital specimens is comparable in three real-time PCR assays. "Human papillomavirus-16 (HPV-16) viral load could be a biomarker predictive of the presence of high-grade cervical lesions. Recently, several real-time PCR assays have been developed to accurately measure HPV-16 viral load. "However, results from various reports using these assays cannot be compared because interassay test correlation has not been documented," scientists in Canada report. "The variability of HPV-16 DNA quantitation was assessed by comparing three real-time PCR assays (HPV-16 L1, HPV-16 E6, and HPV-16 E6 PG) applied on...
Source: Women's Health Weekly (2005-11-24)
|
